idiotypic vaccine comprising VK3-20 protein (areta International)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameidiotypic vaccine comprising VK3-20 protein (areta International)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator Companiesareta International Srl

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive Companiesareta International Srl

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A